ArticleCardiovascular drugs and therapy2026

Reconsidering the Association Between GLP-1 Receptor Agonists and Atrial Fibrillation Risk in Chronic Kidney Disease.

Wei Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.